ACTA1 p.Gln248=
c.744G>A · rs1331857493 · VCV1589183
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP 1.7 | GERP -0.32, phastCons 1 |
| Overall | ||
| CADD | 12.05 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| African / African-Americangrpmax | 0.00401% | 24,943 |
| South Asian | 0.0011% | 91,004 |
| European (non-Finnish) | 8.48e-05% | 1,179,802 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ACTA1
- Protein
- p.Gln248=
- Coding
- c.744G>A
- MANE Select
- NM_001100
- dbSNP
- rs1331857493
- Type
- single nucleotide variant
- Location
- chr1:229432058 (GRCh38)
- Gene constraint
- LOEUF 0.931 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 95.21 · 5 PDB
- Residue 248
- a UniProt-annotated variant site (in cmyo2a)
Disease context
congenital myopathy 2a, typical, autosomal dominant — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Congenital myopathy with excess of thin filaments (Orphanet):
- Inheritance
- Autosomal dominant
Similar variants
- ACTA1 p.Gln248Lys Uncertain significance ★ ⚠ same residue
- ACTA1 c.617-5C>A Likely pathogenic ★★★ same condition
- ACTA1 c.990+1G>T Pathogenic ★★★ same condition
- ACTA1 p.Asp13Asn Likely pathogenic ★★★ same condition
- ACTA1 p.Asp290His Pathogenic ★★★ same condition
- ACTA1 p.Asp58Asn Likely pathogenic ★★★ same condition
- ACTA1 p.Cys376Phe Likely pathogenic ★★★ same condition
- ACTA1 p.Glu102Lys Likely pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/acta1-p-gln248 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown